zPREDICTA
Laboratory
United States of America (USA), North America
zPREDICTA is developing an in vitro human airway model to screen new and repurposed agents against SARS-CoV-2. Our reconstructed lung (r-Lung-SARS-CoV-2) platform is designed to assist pharmaceutical, biotech, and academic researchers in identifying antivirals for COVID-19.